FBN1 and carcinoma: In another study conducted in patients with colon carcinoma, it was observed that asprosin expression was increased in carcinoma tissues compared to healthy tissues [19]. Asprosin is thought to be a promising marker for the early diagnosis of pancreatic cancer [20].